{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:54:54Z","timestamp":1791226494711,"version":"4.1.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"DOI":"10.1007\/s11606-026-10880-y","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:30:35Z","timestamp":1791225035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hospitals Are an Opportunity to Close the Osteoporosis Treatment Gap"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5368-1514","authenticated-orcid":false,"given":"Annie W.","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Ritchey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"10880_CR1","doi-asserted-by":"publisher","unstructured":"Silverstein WK, Mayrer BM, Stall NM, Zipursky JS, Anderson TS. Underprescribing of Antifracture Medications Following Non-Traumatic Fracture: A Retrospective Cohort Study. J Gen Intern Med. Jul 31 2026;\u00a0https:\/\/doi.org\/10.1007\/s11606-026-10659-1.","DOI":"10.1007\/s11606-026-10659-1"},{"key":"10880_CR2","doi-asserted-by":"publisher","unstructured":"Conley RB, Adib G, Adler RA, et al. Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition. J Bone Miner Res. Jan 2020;35(1):36\u201352.\u00a0https:\/\/doi.org\/10.1002\/jbmr.3877.","DOI":"10.1002\/jbmr.3877"},{"key":"10880_CR3","doi-asserted-by":"publisher","unstructured":"Leibson CL, Tosteson AN, Gabriel SE, Ransom JE, Melton LJ. Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc. Oct 2002;50(10):1644\u201350.\u00a0https:\/\/doi.org\/10.1046\/j.1532-5415.2002.50455.x.","DOI":"10.1046\/j.1532-5415.2002.50455.x"},{"key":"10880_CR4","doi-asserted-by":"publisher","unstructured":"Lyles KW, Colon-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. Nov 1 2007;357(18):1799\u2013809.\u00a0https:\/\/doi.org\/10.1056\/NEJMoa074941.","DOI":"10.1056\/NEJMoa074941"},{"key":"10880_CR5","doi-asserted-by":"publisher","unstructured":"Fan W, Sun X, Leder BZ, et al. Zoledronic acid for hip fracture during initial hospitalization. J Bone Miner Res. Aug 21 2024;39(8):1061\u20131070.\u00a0https:\/\/doi.org\/10.1093\/jbmr\/zjae101.","DOI":"10.1093\/jbmr\/zjae101"},{"key":"10880_CR6","doi-asserted-by":"publisher","unstructured":"Desai RJ, Mahesri M, Abdia Y, et al. Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis. JAMA Netw Open. Jul 6 2018;1(3):e180826.\u00a0https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.0826.","DOI":"10.1001\/jamanetworkopen.2018.0826"},{"key":"10880_CR7","doi-asserted-by":"publisher","unstructured":"Chattaris T, Oh G, Gouskova NA, Kim DH, Kiel DP, Berry SD. Osteoporosis Medications Prevent Subsequent Fracture in Frail Older Adults. J Bone Miner Res. Nov 2022;37(11):2103\u20132111.\u00a0https:\/\/doi.org\/10.1002\/jbmr.4693.","DOI":"10.1002\/jbmr.4693"},{"key":"10880_CR8","doi-asserted-by":"publisher","unstructured":"Silverstein WK, Wang S, Alavinejad M, et al. Antiosteoporosis Medication Prescriptions After Fragility Fractures. JAMA Netw Open. Oct 1 2024;7(10):e2438393. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.38393.","DOI":"10.1001\/jamanetworkopen.2024.38393"},{"key":"10880_CR9","doi-asserted-by":"publisher","unstructured":"Silverstein WK, Mayrer BM, Stall NM, Zipursky JS, Anderson TS. Underprescribing of antifracture medications following non-traumatic fracture: A retrospective cohort study. J Gen Intern Med. 2026;\u00a02026 Jul 31. https:\/\/doi.org\/10.1007\/s11606-026-10659-1. Epub ahead of print.\u00a0","DOI":"10.1007\/s11606-026-10659-1"},{"key":"10880_CR10","doi-asserted-by":"publisher","unstructured":"Larose G, Al-Azazi S, Lix LM, Bohm E, Leslie WD. Introduction of an order set after hip fracture improves osteoporosis medication initiation and persistence: a population-based before-after analysis. Osteoporos Int. Oct 2024;35(10):1729\u20131736.\u00a0https:\/\/doi.org\/10.1007\/s00198-024-07131-3.","DOI":"10.1007\/s00198-024-07131-3"},{"key":"10880_CR11","doi-asserted-by":"publisher","unstructured":"Billups SJ, Fixen DR, Schilling LM, El-Sheikh A, Marcus AM, Rothman MS. Lessons Learned: Evaluation of Fracture Liaison Service Quality Improvement Efforts in a Large Academic Healthcare System. J Gen Intern Med. Jun 2024;39(8):1407\u20131413. https:\/\/doi.org\/10.1007\/s11606-023-08568-8.","DOI":"10.1007\/s11606-023-08568-8"},{"key":"10880_CR12","unstructured":"American Orthopaedic Association: Own the Bone. Accessed August 11, 2026.\u00a0https:\/\/www.ownthebone.org\/."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10880-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-026-10880-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10880-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:30:36Z","timestamp":1791225036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-026-10880-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":12,"alternative-id":["10880"],"URL":"https:\/\/doi.org\/10.1007\/s11606-026-10880-y","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"26 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}